Research Insight

Novartis study shows Onbrez® Breezhaler® is superior to salmeterol...

Results of the Phase III INSIST study show that Onbrez® Breezhaler® (indacaterol) given once-daily is significantly better at improving lung function and reducing breathlessness than...

Genetic substudy shows fewer major cardiovascular events with ticagrelor...

A new genetic substudy of PLATO showed that the effects on a combined primary endpoint of cardiovascular death, myocardial infarction, or stroke seen in Acute...

New Study Reinforces Safety Profile of GARDASIL®, the Cervical...

Merck introduced GARDASIL® , the world's first cervical cancer vaccine, a vaccine that can also help to prevent vulvar and vaginal cancers and genital warts...

Amylin Pharmaceuticals, Inc. and Eli Lilly and Company announced...

Amylin Pharmaceuticals, Inc. and Eli Lilly and Company announced final results from a retrospective study including more than 260,000 patients that showed the risk of...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read